TRENTON, NJ – DECEMBER 19, 2022 – Earlier today, the New Jersey State Senate joined its Assembly counterpart in approving legislation that seeks to remove financial barriers to lifesaving colorectal cancer screening.
TRENTON, NJ – DECEMBER 15, 2022 – Earlier today, the New Jersey General Assembly approved legislation that seeks to remove financial barriers to lifesaving cancer screening.
ALBANY, NY – DECEMBER 15, 2022 – The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Ca
ALBANY, NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany.
The following was originally published in the Empire Report on December 6, 2022.
RICHMOND, VA– November 30, 2022 – A statement from Brian Donohue, Director of Government Relations at the American Cancer Society Cancer Action Network in Virginia, follows on the death of Congressional Representative to Virginia’s 4th District, Donald McEachin, from his battle with co
Washington, D.C.— Grupos de pacientes que representan a millones de personas con condiciones de salud graves presentaron hoy un amicus brief (escrito legal amistoso) en el que instan al Tribunal de EE. UU. en el Distrito Norte de Texas
Organizaciones nacionales sin fines de lucro, incluyendo a la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN), junto a defensores contra el cáncer colorrectal, celebran que los beneficiarios de Medicare ya no enfrentarán costos de bolsillo para una colonoscopia necesaria despúes de una prueba de detección no invasiva positiva.
Today U.S. District Court Judge Reed O’Connor issued a ruling that may lead Affordable Care Act-compliant health plans to deny coverage for or reinstate cost-sharing for certain preventive health services.
Los Centros de Servicios de Medicare y Medicaid (CMS, por sus siglas en inglés) publicaron los cambios propuestos al programa de Medicare de 2023 que, si se finaliza, eliminarían los costos compartidos de las colonoscopias después de una prueba de detección no invasiva positiva y reducirían la edad mínima para la detección del cáncer colorrectal a 45 años de edad.